Safety and Tumor Specificity of Cetuximab-IRDye800 for Surgical Navigation in Head and Neck CancerEben L. Rosenthal, Kurt R. Zinn, Yolanda E. Hartman et al.|Clinical Cancer Research|2015Cited by 477
Oncologic Procedures Amenable to Fluorescence-guided SurgeryKiranya E. Tipirneni, Eben L. Rosenthal, Jason M. Warram et al.|Annals of Surgery|2016Cited by 155
Sensitivity and Specificity of Cetuximab-IRDye800CW to Identify Regional Metastatic Disease in Head and Neck CancerEben L. Rosenthal, Jason M. Warram, Lindsay S. Moore et al.|Clinical Cancer Research|2017Cited by 152
Successful Translation of Fluorescence Navigation During Oncologic Surgery: A Consensus ReportEben L. Rosenthal, Gooitzen M. van Dam, Jason M. Warram et al.|Journal of Nuclear Medicine|2015Cited by 147
In Vivo Fluorescence Immunohistochemistry: Localization of Fluorescently Labeled Cetuximab in Squamous Cell CarcinomasEsther de Boer, Margaret Brandwein‐Gensler, Matthew D. Tucker et al.|Scientific Reports|2015Cited by 101